Published in J Nucl Med on August 18, 2009
Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma. Cancer (2011) 1.11
Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Eur J Nucl Med Mol Imaging (2011) 1.00
18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different. Skeletal Radiol (2011) 0.98
PET/CT in primary musculoskeletal tumours: a step forward. Eur Radiol (2010) 0.97
18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors. Pediatr Radiol (2011) 0.97
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters. Eur J Nucl Med Mol Imaging (2010) 0.93
Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer. Nucl Med Mol Imaging (2012) 0.92
¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma. Eur J Nucl Med Mol Imaging (2013) 0.89
Evaluation of static and dynamic MRI for assessing response of bone sarcomas to preoperative chemotherapy: Correlation with histological necrosis. Indian J Radiol Imaging (2015) 0.84
Comparison of (18)F-FDG PET/CT and (99 m)Tc-MDP bone scintigraphy for detection of bone metastasis in osteosarcoma. Skeletal Radiol (2013) 0.84
Prognostic value of radiological response to chemotherapy in patients with osteosarcoma. PLoS One (2013) 0.83
Role of FDG-PET/CT for monitoring soft tissue tumors. Oncol Lett (2014) 0.82
Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours. Eur J Nucl Med Mol Imaging (2010) 0.82
Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results. Skeletal Radiol (2012) 0.81
Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI. Br J Cancer (2015) 0.80
The Role of (18)F-FDG PET/CT as a Prognostic Factor in Patients with Synovial Sarcoma. Nucl Med Mol Imaging (2014) 0.80
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas. Eur J Nucl Med Mol Imaging (2016) 0.79
Positron emission tomography/computed tomography for bone tumors (Review). Oncol Lett (2014) 0.78
Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome. J Bone Joint Surg Am (2014) 0.77
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential ¹⁸F-FDG PET/CT and MRI. Eur J Nucl Med Mol Imaging (2014) 0.77
Effects of neoadjuvant chemotherapy on image-directed planning of surgical resection for distal femoral osteosarcoma. J Bone Joint Surg Am (2012) 0.77
Prediction of response to neoadjuvant chemotherapy in osteosarcoma using dual-phase (18)F-FDG PET/CT. Eur Radiol (2015) 0.76
Clinical usefulness of post-operative 18F-fluorodeoxyglucose positron emission tomography-computed tomography in canine hemangiosarcoma. J Vet Sci (2016) 0.75
FDG Whole-Body PET/MRI in Oncology: a Systematic Review. Nucl Med Mol Imaging (2016) 0.75
A new relative tumor sizing method in epi-metaphyseal osteosarcoma. BMC Cancer (2015) 0.75
A comparison of the predicted risk for cardiovascular disease between HIV-infected and uninfected persons in Korea. Scand J Infect Dis (2013) 1.42
Alumina-on-alumina total hip arthroplasty. A five-year minimum follow-up study. J Bone Joint Surg Am (2005) 1.39
Red blood cell distribution width is an independent predictor of mortality in patients with gram-negative bacteremia. Shock (2012) 1.34
Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol (2009) 1.24
Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry. Breast (2011) 1.21
MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci U S A (2012) 1.18
Transfer of metallic debris from the metal surface of an acetabular cup to artificial femoral heads by scraping: comparison between alumina and cobalt-chrome heads. J Biomed Mater Res B Appl Biomater (2008) 1.15
Clinical characteristics and treatment outcomes of 3 subtypes of achalasia according to the chicago classification in a tertiary institute in Korea. J Neurogastroenterol Motil (2013) 1.14
Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults? J Gastroenterol Hepatol (2013) 1.11
Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables. Breast Cancer Res Treat (2007) 1.10
Surgical complications after robotic thyroidectomy for thyroid carcinoma: a single center experience with 3,000 patients. Surg Endosc (2014) 1.09
AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death. Cardiovasc Res (2009) 1.09
RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma. Pediatr Blood Cancer (2010) 1.03
Ezrin expression predicts survival in stage IIB osteosarcomas. Clin Orthop Relat Res (2007) 1.03
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus. Mol Ther (2012) 1.02
Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma. Cancer Res (2012) 1.01
time dependency of prognostic factors in patients with stage II osteosarcomas. Clin Orthop Relat Res (2007) 1.01
Trend of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in an institution with a high rate of MRSA after the reinforcement of antibiotic stewardship and hand hygiene. Am J Infect Control (2013) 1.00
Spinal cord tanycytic ependymoma associated with neurofibromatosis type 2. J Clin Neurosci (2010) 0.98
Prognostic effect of pathologic fracture in localized osteosarcoma: a cohort/case controlled study at a single institute. J Surg Oncol (2009) 0.98
Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma. Clin Orthop Relat Res (2011) 0.98
Osteogenic abilities of bone marrow stromal cells are not defective in patients with osteonecrosis. Int Orthop (2008) 0.97
Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer. Oncology (2009) 0.96
Efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy. J Gastroenterol Hepatol (2014) 0.96
Stereotactic body radiotherapy for isolated para-aortic lymph node recurrence after curative resection in gastric cancer. J Korean Med Sci (2009) 0.95
Bone mineral density according to age, bone age, and pubertal stages in korean children and adolescents. J Clin Densitom (2009) 0.94
Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response. J Orthop Sci (2009) 0.93
Cardiac triglyceride accumulation following acute lipid excess occurs through activation of a FoxO1-iNOS-CD36 pathway. Free Radic Biol Med (2011) 0.93
The increase in cardiac pyruvate dehydrogenase kinase-4 after short-term dexamethasone is controlled by an Akt-p38-forkhead box other factor-1 signaling axis. Endocrinology (2010) 0.93
The prognostic factors of recurrent GCT: a cooperative study by the Eastern Asian Musculoskeletal Oncology Group. J Orthop Sci (2011) 0.92
Tumor volume increase during preoperative chemotherapy as a novel predictor of local recurrence in extremity osteosarcoma. Ann Surg Oncol (2011) 0.92
Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma. Pediatr Blood Cancer (2008) 0.92
Stereotactic body radiation therapy boost in locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2009) 0.92
Postoperative infection and survival in osteosarcoma patients. Ann Surg Oncol (2008) 0.91
Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma. Jpn J Clin Oncol (2008) 0.91
Pasteurized autograft for intercalary reconstruction: an alternative to allograft. Clin Orthop Relat Res (2007) 0.91
Vesicle formed by amphiphilc cucurbit[6]uril: versatile, noncovalent modification of the vesicle surface, and multivalent binding of sugar-decorated vesicles to lectin. J Am Chem Soc (2005) 0.90
Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients. Ann Surg Oncol (2007) 0.90
Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity. Hum Gene Ther (2005) 0.90
Treatment outcome of Korean patients with localized Ewing sarcoma family of tumors: a single institution experience. Jpn J Clin Oncol (2011) 0.90
Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer. Breast Cancer Res Treat (2010) 0.89
Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus. Mol Ther (2008) 0.89
¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma. Eur J Nucl Med Mol Imaging (2013) 0.89
Combination of 18F-FDG PET/CT and diffusion-weighted MR imaging as a predictor of histologic response to neoadjuvant chemotherapy: preliminary results in osteosarcoma. J Nucl Med (2013) 0.88